Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF STOCKHOLDERS EQUITY

v3.22.4
STATEMENTS OF STOCKHOLDERS EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balances, Beginning at Dec. 31, 2020 $ 830 $ 57,905,164 $ (27,965,105) $ 29,940,889
Balances, Beginning (in shares) at Dec. 31, 2020 8,305,075      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense   322,881   322,881
Exercise of warrants $ 3 197,559   197,562
Exercise of warrants (in shares) 25,315      
Net loss     (15,960,268) (15,960,268)
Balances, Ending at Dec. 31, 2021 $ 833 58,425,604 (43,925,373) 14,501,064
Balances, Ending (in shares) at Dec. 31, 2021 8,330,390      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common shares in public offering, net of costs $ 1,000 4,489,605   4,490,605
Issuance of common shares in public offering, net of costs (shares) 10,000,000      
Share-based compensation expense   582,659   582,659
Net loss     (12,247,834) (12,247,834)
Balances, Ending at Dec. 31, 2022 $ 1,833 $ 63,497,868 $ (56,173,207) $ 7,326,494
Balances, Ending (in shares) at Dec. 31, 2022 18,330,390